Results 91 to 100 of about 26,736 (234)

Potential clinical application of anti-Müllerian hormone testing in radioiodine treatment of thyroid carcinoma

open access: yesBMC Research Notes
Differentiated thyroid cancer is the most common endocrinological malignancy. Radioiodine treatment has a clear benefit in locally aggressive and metastatic cancers. There are discussions about long-term and acute adverse events.
Barbora Havlínová   +3 more
doaj   +1 more source

Incomplete ovarian tissue removal in female dogs and cats [PDF]

open access: yes, 2016
Incomplete ovariectomy (IO) is the unintentional partial or complete lack of removal of one or both ovaries during an ovariohysterectomy or ovariectomy procedure, and is often referred to as ‘ovarian remnant syndrome’.
Davies N. L.   +5 more
core   +1 more source

Safety and efficacy of the therapy with CD4 + CD25highCD127‐T regulatory cells: When paediatric patient becomes adult

open access: yesDiabetes, Obesity and Metabolism, Volume 28, Issue 2, Page 1392-1402, February 2026.
Abstract Aim CD4 + CD25highCD127‐T regulatory cells (Tregs) remain a drug candidate for immunotherapy of type 1 diabetes. We completed three trials testing Tregs in recently diagnosed type 1 diabetes children. Here, we looked for long‐term safety and efficacy aspects important in the authorisation of this therapy.
Marta Bandura   +18 more
wiley   +1 more source

Anti-Mullerian hormone: reality check [PDF]

open access: yesHuman Reproduction, 2013
Christine A, Clark   +2 more
openaire   +2 more sources

Effects of growth factors and receptor blockade on gastrointestinal cancer [PDF]

open access: yes, 2004
The advent of recombinant peptide technology offers the potential to use one or several peptides to treat a variety of gastrointestinal conditions. However, although cell culture and animal models have shown proof of concept, we are still at a relatively
Ghosh, S, Playford, RJ, Wassan, H
core   +2 more sources

Establishment of age-related AMH screening cutoffs in Chinese women with PCOS: a retrospective study using propensity score matching analysis

open access: yesBMC Endocrine Disorders
Background Polycystic ovary syndrome (PCOS) is a common endocrine disorder that affects 5–18% of women worldwide. This disorder is characterized by two core pathological features: ovulatory dysfunction and hyperandrogenism.
Zhen Wang   +5 more
doaj   +1 more source

Anti-Mullarian Hormone As A Diagnostic Marker of Polycystic Ovary Syndrome

open access: yesPakistan Armed Forces Medical Journal
Objective: To determine the utility of Anti-mullerian hormone (AMH) as a diagnostic marker of Polycystic ovarian syndrome (PCOS). Study Design: Comparative cross-sectional study Place and Duration of the Study: Department of Chemical Pathology and ...
Shabana Abbas   +5 more
doaj   +1 more source

Serum inhibin B values in infertile patients

open access: yesАндрология и генитальная хирургия, 2016
The increased interest in inhibin B generated by Sertoli cells is due to the fact that on the basis of findings, some authors recorded a relationship between the level of this hormone and infertility.
Z. A. Kadyrov   +2 more
doaj   +1 more source

Individual 17-Hydroxyprogesterone Responses to hCG Are Not Correlated With Follicle Size in Polycystic Ovary Syndrome. [PDF]

open access: yes, 2019
Context:In women with polycystic ovary syndrome (PCOS), 17-hydroxyprogesterone (17-OHP) responses to gonadotropin stimulation vary from increased to indistinguishable compared with normal controls.
Chang, R Jeffrey   +5 more
core   +1 more source

Home - About - Disclaimer - Privacy